Fady Ibraham Malik sold $748K of Cytokinetics (CYTK)

Executed Mar 17, disclosed Mar 18, 1 day later.

Value, as filed

$748K

12,033 sh across 2 lots

Executed

Mar 17

the trade date, as filed

Disclosed

Mar 18

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Fady Ibraham Malik EVP Research & Development profile →

Fady Ibraham Malik (EVP Research & Development) filed 19 Form 4 reports in the trailing twelve months (0 purchases, 19 sales), most often in Cytokinetics, Incorporated (CYTK). The largest single filing was $748K of CYTK (12,033 sh across 2 lots, as filed), executed Mar 17.

The name

CYTK

Cytokinetics, Incorporated CYTK · Healthcare · 121 filings in 24 months ticker →

Healthcare · Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators an…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Fady Ibraham Malik in CYTK

CYTKSALE Cytokinetics, Incorporated $220K
3,500 sh × $62.93
Exec Nov 3
Filed Nov 3 · 4:38 PM ET CYTKSALE Cytokinetics, Incorporated $224K
3,500 sh × $64.01
Exec Oct 20
Filed Oct 20 · 4:21 PM ET CYTKSALE Cytokinetics, Incorporated $215K
3,500 sh × $61.38
Exec Oct 6
Filed Oct 6 · 4:25 PM ET CYTKSALE Cytokinetics, Incorporated $239K
3,500 sh × $68.29
Exec Sep 22
Filed Sep 22 · 6:14 PM ET CYTKSALE Cytokinetics, Incorporated $264K
3,500 sh × $75.46
Exec Sep 8
Filed Sep 8 · 4:38 PM ET CYTKSALE Cytokinetics, Incorporated $265K
3,500 sh × $75.82
Exec Aug 18
Filed Aug 18 · 4:38 PM ET CYTKSALE Cytokinetics, Incorporated $282K
3,500 sh × $80.59
Exec Jul 21
Filed Jul 23 · 4:09 PM ET CYTKSALE Cytokinetics, Incorporated $303K
3,500 sh × $86.62
Exec Jul 7
Filed Jul 7 · 5:06 PM ET